Market Overview

Benzinga's Top Upgrades

Share:
Benzinga's Top Upgrades
Related CELG
Early Clinical Data Released For Celgene's CELMoD
Mike Khouw Sees Unusual Options Activity In Celgene
Celgene's Trio Of New Drugs Could Tack On $3 Billion-Plus: RBC (Investor's Business Daily)
Related FB
Mobile Advertising's Next Barrier: Texts, iMessages, WhatsApp And More
AXT Trading At Its Highest Levels Since 2012; Northland Raises Price Target
Google Back In Twitter M&A Talk As AT&T, Disney Speculation Fades (Investor's Business Daily)

Analysts at Deutsche Bank upgraded Celgene (NASDAQ: CELG) from “hold” to “buy.” The target price has been raised from $105.00 to $143.00. Celgene closed at $115.95 yesterday.

Analysts at Argus Research upgraded Facebook (NASDAQ: FB) from “hold” to “buy.” The target price for Facebook is set to $36.00. Facebook shares closed at $27.07 yesterday.

Stifel Nicolaus upgraded Teradata (NYSE: TDC) from “hold” to “buy.” The target price for Teradata is set to $63. Teradata's shares closed at $51.89 yesterday.

JP Morgan upgraded Mobile TeleSystems (NYSE: MBT) from “neutral” to “overweight.” Mobile TeleSystems' shares closed at $19.84 yesterday.

Latest Ratings for CELG

DateFirmActionFromTo
Sep 2016CitigroupMaintainsBuy
Aug 2016BTIG ResearchUpgradesNeutralBuy
Jul 2016StifelInitiates Coverage onBuy

View More Analyst Ratings for CELG
View the Latest Analyst Ratings

Posted-In: top upgradesUpgrades Analyst Ratings

 

Related Articles (CELG + FB)

View Comments and Join the Discussion!